199,423 Shares in Kenvue Inc. $KVUE Purchased by OP Asset Management Ltd

OP Asset Management Ltd bought a new position in Kenvue Inc. (NYSE:KVUE) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 199,423 shares of the company’s stock, valued at approximately $3,438,000.

Several other hedge funds and other institutional investors have also recently modified their holdings of KVUE. Oak Thistle LLC purchased a new position in shares of Kenvue during the 4th quarter valued at $1,563,000. Mirae Asset Global Investments Co. Ltd. raised its position in shares of Kenvue by 25.8% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 410,874 shares of the company’s stock worth $7,088,000 after buying an additional 84,219 shares in the last quarter. SG Americas Securities LLC raised its position in shares of Kenvue by 3,889.9% in the fourth quarter. SG Americas Securities LLC now owns 3,075,723 shares of the company’s stock worth $53,056,000 after buying an additional 2,998,635 shares in the last quarter. Moors & Cabot Inc. boosted its stake in Kenvue by 66.9% during the third quarter. Moors & Cabot Inc. now owns 313,122 shares of the company’s stock valued at $5,082,000 after buying an additional 125,517 shares during the period. Finally, Cohen Capital Management Inc. bought a new stake in Kenvue during the fourth quarter valued at $2,448,000. 97.64% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

KVUE has been the topic of a number of research analyst reports. Barclays decreased their target price on Kenvue from $19.00 to $18.00 and set an “equal weight” rating on the stock in a research note on Tuesday, April 14th. Zacks Research upgraded Kenvue from a “hold” rating to a “strong-buy” rating in a research report on Friday, May 8th. Citigroup cut their price objective on Kenvue from $20.00 to $19.00 and set a “neutral” rating for the company in a report on Wednesday, April 15th. Argus raised shares of Kenvue to a “hold” rating in a research note on Friday, March 6th. Finally, UBS Group lowered their target price on shares of Kenvue from $19.00 to $18.00 and set a “neutral” rating on the stock in a research note on Tuesday, April 7th. One analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and twelve have issued a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $19.33.

Insider Buying and Selling

In other Kenvue news, General Counsel Matthew Orlando sold 38,491 shares of the stock in a transaction that occurred on Friday, May 8th. The shares were sold at an average price of $17.66, for a total transaction of $679,751.06. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 1.59% of the stock is owned by insiders.

Kenvue Stock Up 1.0%

KVUE opened at $19.14 on Friday. The business’s fifty day simple moving average is $17.66 and its 200 day simple moving average is $17.63. Kenvue Inc. has a 52 week low of $14.02 and a 52 week high of $22.87. The company has a quick ratio of 0.70, a current ratio of 0.98 and a debt-to-equity ratio of 0.67. The stock has a market cap of $36.76 billion, a PE ratio of 22.52, a P/E/G ratio of 1.44 and a beta of 0.54.

Kenvue (NYSE:KVUE) last issued its quarterly earnings results on Thursday, May 7th. The company reported $0.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.27 by $0.05. The firm had revenue of $3.91 billion during the quarter, compared to analyst estimates of $3.84 billion. Kenvue had a return on equity of 20.81% and a net margin of 10.61%.The company’s revenue was up 4.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.24 earnings per share. As a group, research analysts expect that Kenvue Inc. will post 1.16 earnings per share for the current fiscal year.

Kenvue Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, May 27th. Shareholders of record on Wednesday, May 13th were paid a $0.2075 dividend. The ex-dividend date of this dividend was Wednesday, May 13th. This represents a $0.83 annualized dividend and a yield of 4.3%. Kenvue’s dividend payout ratio is currently 97.65%.

Kenvue Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.